Evidence map›Paper›PMID 22291998›Full record

ArticlePloS one2012

Characterization of NLRP12 during the development of allergic airway disease in mice.

Irving C Allen, John D Lich, Janelle C Arthur, Corey M Jania, Reid A Roberts, Justin B Callaway, Stephen L Tilley, Jenny P-Y Ting

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Inflammasome Activity in Non-Microbial Lung Inflammation.Journal of environmental immunology and toxicology · 2014
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Irving C AllenLineberger Comprehensive Cancer Center, Institute of Inflammatory Diseases and Center for Translational Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
John D Lich
Janelle C Arthur
Corey M Jania
Reid A Roberts
Justin B Callaway
Stephen L Tilley
Jenny P-Y Ting

Funding

Somatostatin analogues as countermeasures against intestinal radiation toxicityU19AI067798 · NIAID · DUKE UNIVERSITY · PI CHAO, NELSON J. · 2005 to 2024
$82.1M
Integrated Training in Cancer Model SystemsT32CA009156 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J. · 1985 to 2020
$19.7M
P2X7 and the Inflammasome Pathways in Lung InflammationU19AI077437 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PEDEN, DAVID B. · 2008 to 2013
$9.2M
THE MICROENVIRONMENT IN ALLOIMMUNITYP01DK038108 · NIDDK · DUKE UNIVERSITY · PI COFFMAN, THOMAS M · 1988 to 2009
$7.1M
PGE2 in the Pathogenesis of Allergic Airways DiseaseR01HL068141 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KOLLER, BEVERLY H · 2001 to 2009
$3.2M
ARTHRITIS AND IMMUNOLOGYT32AR007416 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JORDAN, JOANNE M. · 1986 to 2009
$2.5M
Innate Immune Response Genes and P. GingivalisR01DE016326 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TING, JENNY P · 2005 to 2009
$2.0M
NLR Regulation of Gastrointestinal Inflammation and TumorigenesisK01DK092355 · NIDDK · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI ALLEN, IRVING C · 2011 to 2015
$709k
NLR regulation of innate immune responses to respiratory virus infectionF32AI082895 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ALLEN, IRVING C · 2009 to 2009
$18k
NCI NIH HHS T32 CA009156NCI NIH HHS T32-CA009156NHLBI NIH HHS HL068141NHLBI NIH HHS R01 HL068141NIAID NIH HHS F32 AI082895NIAID NIH HHS F32-AI-082895-01NIAID NIH HHS U19 AI067798NIAID NIH HHS U19-AI067798NIAID NIH HHS U19 AI077437NIAID NIH HHS U19-AI077437NIAMS NIH HHS T32 AR007416NIAMS NIH HHS T32-AR007416NIDCR NIH HHS DE016326NIDCR NIH HHS R01 DE016326NIDDK NIH HHS DK38108,NIDDK NIH HHS K01 DK092355NIDDK NIH HHS P01 DK038108PHS HHS A1063031,
6 · The paper itself

Abstract

Among the 22 members of the nucleotide binding-domain, leucine rich repeat-containing (NLR) family, less than half have been functionally characterized. Of those that have been well studied, most form caspase-1 activating inflammasomes. NLRP12 is a unique NLR that has been shown to attenuate inflammatory pathways in biochemical assays and mediate the lymph node homing of activated skin dendritic cells in contact hypersensitivity responses. Since the mechanism between these two important observations remains elusive, we further evaluated the contribution of NLRP12 to organ specific adaptive immune responses by focusing on the lung, which, like skin, is exposed to both exogenous and endogenous inflammatory agents. In models of allergic airway inflammation induced by either acute ovalbumin (OVA) exposure or chronic house dust mite (HDM) antigen exposure, Nlrp12(-/-) mice displayed subtle differences in eosinophil and monocyte infiltration into the airways. However, the overall development of allergic airway disease and airway function was not significantly altered by NLRP12 deficiency. Together, the combined data suggest that NLRP12 does not play a vital role in regulating Th2 driven airway inflammation using common model systems that are physiologically relevant to human disease. Thus, the allergic airway inflammation models described here should be appropriate for subsequent studies that seek to decipher the contribution of NLRP12 in mediating the host response to agents associated with asthma exacerbation.

Indexed as

AnimalsAntigens, DermatophagoidesBronchoalveolar Lavage FluidDisease Models, AnimalFemaleInflammationIntracellular Signaling Peptides and ProteinsMaleMiceMice, Inbred C57BLMice, KnockoutOvalbuminRespiratory HypersensitivityRespiratory Tract DiseasesAntigens, DermatophagoidesIntracellular Signaling Peptides and ProteinsNLRP12 protein, mouseOvalbumin

Identifiers

PMID22291998
PMCPMC3264608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.